MedTrace Logo

Cardiopulmonary Exercise Testing in Severe Mitral Regurgitation

NCT03154034 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2021-10-11

No results posted yet for this study

Summary

The purpose of this study is the evaluation of cardiac and pulmonary response to cardiopulmonary exercise in severe mitral regurgitation and its variation under treatment (surgical mitral valve repair, percutaneous mitral valve repair, optimal medical treatment). The study is conducted as a prospective, observational, single-center study. Patients suffering from symptomatic severe mitral regurgitation will be eligible, if they are referred to the University Hospital of Regensburg, Germany, for further diagnostic procedures and heart team discussion. Cardiopulmonary exercise testing is performed comprising standardized stress echocardiography as well as ergospirometry. Additional detailed assessment will be conducted including standardized questionary, clinical examination, transesophageal echocardiography and measurement of biomarkers.

Conditions

  • Mitral Valve Regurgitation
  • Pulmonary Hypertension

Sponsors & Collaborators

  • University Hospital Regensburg

    lead OTHER

Principal Investigators

  • Alexander Dietl, MD · University Hospital Regensburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-13
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03154034 on ClinicalTrials.gov